More Telix Pharmaceuticals Limited news
Telix Pharmaceuticals LimitedASX: TLX

Telix and ANMI Expand PSMA Imaging Partnership

Oct 14, 2018 at 5:49 PM EDT · Issued by Telix Pharmaceuticals Limited

Filed with ASX · Oct 14, 2018 at 5:49 PM EDT

On 6ix: 6ix.com/news/telix-and-anmi-expand-psma-imaging-partnership

Watch Telix Pharmaceuticals' latest call↗Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call↗

View Attachment

6ix hasn’t read this filing yet.

Telix Pharmaceuticals Limited on 6ix

Earlier from Telix Pharmaceuticals

  • Strategic Collaboration Agreement with GenesisCareOct 9, 2018
  • Telix completes acquisition of Atlab PharmaSep 10, 2018
  • TLX receives ethics approval to commence Glioblastoma StudySep 3, 2018
  • Half Yearly Report and AccountsAug 30, 2018
  • Telix files Ph III trial for Kidney Cancer Imaging in EuropeAug 22, 2018

Later from Telix Pharmaceuticals

  • Interim Analysis of ZIR-DOSE Study Shows Improved DosimetryOct 14, 2018
  • Telix Commences ZIRCON Phase III Renal Cancer Imaging TrialOct 22, 2018
  • Appendix 4C - September QuarterOct 30, 2018
  • Telix Acquires Advanced Nuclear Medicine Ingredients SANov 25, 2018
  • ANMI Transaction - Market BriefingNov 25, 2018
All Telix Pharmaceuticals news releases↗

Follow Telix Pharmaceuticals into a list and get an email when it puts out news.

Follow Telix Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer